--- title: "Shandong Weigao Group Medical Polymer Co. Ltd. Held Extraordinary General Meeting" description: "Shandong Weigao Group Medical Polymer Co. Ltd. held an Extraordinary General Meeting on February 12, 2026, where the resolution outlined in the meeting notice was approved. This information was genera" type: "news" locale: "en" url: "https://longbridge.com/en/news/275696922.md" published_at: "2026-02-12T04:00:36.000Z" --- # Shandong Weigao Group Medical Polymer Co. Ltd. Held Extraordinary General Meeting > Shandong Weigao Group Medical Polymer Co. Ltd. held an Extraordinary General Meeting on February 12, 2026, where the resolution outlined in the meeting notice was approved. This information was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. held an Extraordinary General Meeting on 12 February 2026. The resolution set out in the meeting notice was approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260212-12022866), on February 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) ### Related Stocks - [159883.CN - Maxwealth CSI All Share Medical Apparatus and Instruments ETF](https://longbridge.com/en/quote/159883.CN.md) - [562600.CN - ChinaAMC CSI All Share Health Care Devices ETF](https://longbridge.com/en/quote/562600.CN.md) - [01066.HK - WEIGAO GROUP](https://longbridge.com/en/quote/01066.HK.md) - [159898.CN - China Merchants CSI All Share Medical Apparatus and Instruments ETF](https://longbridge.com/en/quote/159898.CN.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 双威医疗保健委任六家投行担任上市承销商 \| 联合早报网 | 双威医疗保健(Sunway Healthcare)已委任六家投资银行作为首次公开售股(IPO)的承销商,计划在马来西亚上市,预计集资超过 30 亿令吉,估值将超过 150 亿令吉。承销商包括马来亚、艾芬黄氏、联昌国际、兴业、肯纳格及大马投资 | [Link](https://longbridge.com/en/news/275451558.md) | | 山东威高集团医用高分子有限公司以 637,200 港元回购了 12 万股 | 山东威高集团医疗高分子股份有限公司于 2026 年 2 月 11 日回购了 120,000 股,平均价格为每股 5.31 港元,总计约为 637,200 港元。这些股份被作为库存股持有。该公告通过香港证券交易所的发行人信息服务发布 | [Link](https://longbridge.com/en/news/275575422.md) | | Allscripts 医疗|8-K:2025 财年营收 5.87 亿美元 | | [Link](https://longbridge.com/en/news/276168463.md) | | ICU 医疗|10-K:2025 财年营收 22.31 亿美元超过预期 | | [Link](https://longbridge.com/en/news/276382836.md) | | 山东威高集团医用高分子有限公司以 323,984 港元回购 61,600 股 | 山东威高集团医疗高分子股份有限公司以每股 5.26 港元的价格回购了 61,600 股,总金额约为 323,984 港元。这些股份将作为库藏股持有 | [Link](https://longbridge.com/en/news/275430404.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.